Clinical Trials Sponsored by Genentec
Total 1716 results
-
Genentech, Inc.RecruitingMultiple MyelomaAustralia, Spain, Israel, Korea, Republic of, Greece, Norway, Denmark
-
Genentech, Inc.RecruitingAge-Related Macular DegenerationFrance, Germany, Israel, United States, Australia, Puerto Rico, Italy
-
Genentech, Inc.RecruitingNon-Hodgkin LymphomaUnited States, Puerto Rico
-
Genentech, Inc.Completed
-
Genentech, Inc.Active, not recruitingColorectal CancerSpain, United States, Australia, Canada
-
Genentech, Inc.CompletedAdvanced Unresectable or Metastatic Solid MalignancyUnited States
-
Genentech, Inc.Active, not recruitingLymphocytic Leukemia, Chronic | Lymphoma, Non HodgkinUnited States, Korea, Republic of, Australia, United Kingdom, Germany, Canada, Spain
-
Genentech, Inc.TerminatedAcute Graft-versus-host DiseaseUnited States, Canada
-
Genentech, Inc.CompletedTHROMBOLYSISUnited States, Canada
-
Genentech, Inc.CompletedUlcerative ColitisItaly, Spain, Serbia, Poland, Russian Federation, United States, Ukraine, Bulgaria, Georgia, Germany, Greece, Hungary, Ireland, Israel, Moldova, Republic of, United Kingdom
-
Genentech, Inc.CompletedBreast CancerUnited States, Spain, Belgium, Australia, United Kingdom
-
Genentech, Inc.CompletedBrain Neoplasms | Non-Small Cell Lung Cancer
-
Genentech, Inc.Completed
-
Genentech, Inc.Completed
-
Genentech, Inc.CompletedColorectal Cancer | Non-Small Cell Lung Cancer
-
Genentech, Inc.WithdrawnChronic Spontaneous Urticaria
-
Genentech, Inc.Approved for marketing
-
Genentech, Inc.CompletedNeoplasmsUnited States, Spain, Belgium, Korea, Republic of, Canada, Australia, France
-
Genentech, Inc.TerminatedAlzheimer's DiseaseUnited States, Spain, Belgium, Australia, Canada, France, Germany, Poland, Italy, Netherlands, United Kingdom, Sweden, Denmark
-
Genentech, Inc.TerminatedModerate-to-severe Allergic AsthmaUnited States
-
Genentech, Inc.CompletedNeoplasmsUnited States, Spain, United Kingdom, France
-
Genentech, Inc.TerminatedBreast CancerUnited States, Korea, Republic of, Spain, Netherlands
-
Genentech, Inc.Completed
-
Genentech, Inc.Approved for marketingMuscular Atrophy, SpinalUnited States
-
Genentech, Inc.CompletedRheumatoid ArthritisUnited States, Serbia, Bulgaria, Ukraine, Poland, Russian Federation, Argentina, Brazil, Colombia, Mexico
-
Genentech, Inc.CompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada
-
Genentech, Inc.Completed
-
Genentech, Inc.Completed
-
Genentech, Inc.Completed
-
Genentech, Inc.CompletedHepatic InsufficiencyUnited States
-
Genentech, Inc.Terminated
-
Genentech, Inc.CompletedHealthy ParticipantsUnited States
-
Genentech, Inc.TerminatedGeographic AtrophyUnited States, Germany
-
Genentech, Inc.CompletedHealthy VolunteersUnited Kingdom
-
Genentech, Inc.CompletedAlzheimer DiseaseUnited States
-
Genentech, Inc.Completed
-
Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States, France, United Kingdom, Belgium, Netherlands
-
Genentech, Inc.Terminated
-
Genentech, Inc.Completed
-
Genentech, Inc.Completed
-
Genentech, Inc.CompletedA Study to Investigate Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Healthy VolunteersHealthy VolunteerUnited States
-
Genentech, Inc.Completed
-
Genentech, Inc.WithdrawnHealthy VolunteerUnited Kingdom
-
Genentech, Inc.CompletedBreast Cancer, Non-small Lung CancerUnited States, Spain, Canada, Belgium
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerUnited States
-
Genentech, Inc.CompletedHealthy VolunteerUnited Kingdom
-
Genentech, Inc.Completed
-
Genentech, Inc.Completed
-
Genentech, Inc.TerminatedLupus Erythematosus, SystemicUnited States
-
Genentech, Inc.CompletedAlzheimer's DiseaseSpain, United States, France